Skip to main content

Biochemical Engineering Journal

  • ISSN: 1369-703X

Next planned ship date: April 25, 2024

  • 5 Year impact factor: 4
  • Impact factor: 3.9

endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, Japan Biochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit… Read more

Subscription options

Next planned ship date:
April 25, 2024

Institutional subscription on ScienceDirect

Request a sales quote
endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, Japan

Biochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here.

The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.

The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:

Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells

Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals


Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution


*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to [email protected] or one of the Editors.